Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE:300026)
China · Delayed Price · Currency is CNY 3.610
+0.040 (1.12%)
At close: Feb 3, 2026
SHE:300026 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -66.13 | 21.47 | 506.63 | 624.24 | 687.32 | 573.39 |
Depreciation & Amortization | 335.18 | 335.18 | 346.11 | 306.8 | 261.47 | 189.99 |
Other Amortization | 33.46 | 33.46 | 27.09 | 30.31 | 32.14 | 27.03 |
Loss (Gain) From Sale of Assets | -1.08 | -1.08 | -1.06 | -0.01 | 2.87 | -0.03 |
Asset Writedown & Restructuring Costs | 47.67 | 47.67 | 27.57 | 2.36 | 81.71 | 24.3 |
Loss (Gain) From Sale of Investments | 5.63 | 5.63 | 1.4 | -3.16 | 22.98 | -2.02 |
Provision & Write-off of Bad Debts | 100.51 | 100.51 | 54.84 | 74.21 | 85.59 | 74.29 |
Other Operating Activities | 217.23 | 97.93 | 78.28 | 57.76 | 54.13 | 46.34 |
Change in Accounts Receivable | -10.92 | -10.92 | 690.83 | 172.98 | -1,041 | -845.38 |
Change in Inventory | 158.12 | 158.12 | 223.74 | -914.09 | 106.36 | -537.93 |
Change in Accounts Payable | 135.65 | 135.65 | -430.08 | 380.85 | 97.1 | 615.77 |
Change in Other Net Operating Assets | 5.19 | 5.19 | 5.51 | 16.45 | -5.51 | 60.28 |
Operating Cash Flow | 883.96 | 852.24 | 1,530 | 745.35 | 391.6 | 196.66 |
Operating Cash Flow Growth | -15.22% | -44.30% | 105.29% | 90.33% | 99.12% | -9.00% |
Capital Expenditures | -178.77 | -193.12 | -347.12 | -770.27 | -677.45 | -563.78 |
Sale of Property, Plant & Equipment | 0.68 | 0.39 | 1.89 | 0.22 | 2.79 | 1.4 |
Cash Acquisitions | - | - | - | - | - | -3.39 |
Divestitures | -1.59 | -1.59 | -53.03 | - | 0.21 | -0.43 |
Investment in Securities | 57.42 | 6.79 | -3.13 | 34.72 | 14.73 | 3.15 |
Other Investing Activities | 1.54 | - | -1.53 | 6.88 | 17.44 | 1.01 |
Investing Cash Flow | -103.44 | -170.26 | -402.92 | -728.44 | -642.27 | -562.04 |
Short-Term Debt Issued | - | - | - | - | - | 0.4 |
Long-Term Debt Issued | - | 56.51 | 439.2 | 843.39 | 1,603 | 1,338 |
Total Debt Issued | 71.7 | 56.51 | 439.2 | 843.39 | 1,603 | 1,339 |
Short-Term Debt Repaid | - | - | - | - | -0.82 | -0.4 |
Long-Term Debt Repaid | - | -868.3 | -1,044 | -802.29 | -967.76 | -535.35 |
Total Debt Repaid | -387.75 | -868.3 | -1,044 | -802.29 | -968.58 | -535.75 |
Net Debt Issued (Repaid) | -316.06 | -811.79 | -604.34 | 41.1 | 634.9 | 803.11 |
Repurchase of Common Stock | - | - | - | - | - | -2.54 |
Common Dividends Paid | -109.43 | -137.11 | -154.7 | -190.79 | -157.84 | -181.96 |
Other Financing Activities | -14.8 | -11.74 | -9.46 | -0.92 | -12.26 | -118.29 |
Financing Cash Flow | -440.29 | -960.64 | -768.5 | -150.6 | 464.8 | 500.31 |
Foreign Exchange Rate Adjustments | 3.48 | 4.29 | 5.49 | 22.91 | -6.27 | -17.65 |
Net Cash Flow | 343.7 | -274.37 | 364.17 | -110.78 | 207.85 | 117.28 |
Free Cash Flow | 705.19 | 659.12 | 1,183 | -24.93 | -285.85 | -367.12 |
Free Cash Flow Growth | -4.38% | -44.28% | - | - | - | - |
Free Cash Flow Margin | 12.84% | 11.40% | 19.36% | -0.38% | -3.73% | -5.66% |
Free Cash Flow Per Share | 0.34 | 0.31 | 0.40 | -0.01 | -0.10 | -0.12 |
Cash Income Tax Paid | 462.76 | 481.3 | 434.17 | 439.93 | 619.4 | 406.76 |
Levered Free Cash Flow | 701.05 | 576.51 | 679.83 | -320.75 | -610.66 | -504.2 |
Unlevered Free Cash Flow | 713.04 | 604.55 | 718.32 | -277.21 | -579.35 | -485.4 |
Change in Working Capital | 211.48 | 211.48 | 489.23 | -347.16 | -836.61 | -736.63 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.